InnoTech Precision Medicine Secures $2.8M in NIH and NSF Funding to Advance Integrated, AI-Driven Multiomics Diagnostics for Head and Neck Cancer.

Innotech Precison Medicine News

InnoTech to Present and Co-Chair at 2025 AADOCR/CADR Conference in NYC

Exciting news from InnoTech Precision Medicine! We’re proud to announce that our CEO and co-founder, Dr. Roya Khosravi-Far, has been invited to give a featured talk and co-chair a scientific session at the 2025 AADOCR/CADR Annual Meeting, taking place in New York City on Saturday, March 15.

Join us for Session ID: 0199 – Oral and Craniofacial Diagnostic Sciences, from 1:30-3:00 PM, where Dr. Khosravi-Far will present our groundbreaking point-of-care diagnostic platform that is transforming the way oropharyngeal squamous cell carcinoma (OPSCC) is detected and monitored.

Our technology enables simultaneous detection of high-risk HPV types and early cancer progression biomarkers–all from a simple saliva sample, with lab-quality results delivered in just 30 minutes at the point of care. This innovation brings speed, accuracy, and accessibility to the forefront of oral cancer diagnostics.

  • Revolutionizing OPSCC diagnosis.
  • Multi-analyte detection in a single non-invasive test.
  • Results in 30 minutes, right where care is delivered.

Don’t miss the opportunity to hear from thought leaders in diagnostic innovation and explore InnoTech’s vision for advancing equitable, real-time cancer diagnostics.